Physician profile
Lev Elterman
NPI 1851377113
$16,314.36
in general payments reported to CMS, 2019-2025
59 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,996 · 2020: $869 · 2021: $1,636 · 2022: $1,451 · 2023: $1,177 · 2024: $1,797 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,363.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Butterfly Network, INC. | $7,168.00 | 2019 | |
| Janssen Biotech, INC. | $1,541.50 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $787.51 | 2021-2025 | Provenge |
| Pfizer INC. | $669.90 | 2019-2025 | |
| Medivators INC. | $500.00 | 2021 | |
| Coloplast Corp | $436.99 | 2019-2025 | Speedicath, Saffron |
| Astellas Pharma US INC | $434.47 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $410.49 | 2023-2025 | Gemtesa, Orgovyx |
| Verity Pharmaceuticals INC. | $352.19 | 2023-2025 | Trelstar, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $288.22 | 2019-2025 | |
| Myovant Sciences INC. | $225.69 | 2021-2022 | |
| Boston Scientific Corporation | $225.51 | 2019-2025 | Rezum Generator, Axonics, Spaceoar Vue System - 10ml |
| Abbvie INC. | $192.06 | 2022-2025 | |
| Medtronic, INC. | $189.68 | 2021-2023 | Interstim |
| Astrazeneca Pharmaceuticals LP | $166.33 | 2020-2021 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lev Elterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.